Recent Venture Capital Activity

 

The Venture Capital world hasn’t slowed too much, as most V.C. firms have been locking in deals remotely. As expected, Healthcare and Tech sectors lead the pack in recent V.C. financings. Here are the most recent Venture Capital deals from this past month:

 

Company: Day One Biopharmaceuticals 
Amount Raised: $60 mm
Funding Round: Series A
Date: 5/21
Lead Investor(s):  Access Industries, Atlas Venture, Canaan Partners 
Company Description: Day One Biopharmaceuticals is an early stage biotech based out of San Francisco, CA. 

Company: Octant 
Amount Raised:  $30mm
Funding Round: Series A
Date: 5/20
Lead Investor(s): Andressen Horowitz, SV Angel, 8VC
Company Description: Octant is an early stage synthetic drug discovery company based out of Emeryville, CA. 

Company: Nautilus Biotechnology 
Amount Raised: $76 mm
Funding Round:  Series B
Date:  5/21
Lead Investor(s): Vulcan Capital
Company Description: Nautilus is an early stage biotechnology company specializing in the development of a revolutionary proteomics platform which would have the ability to deliver quality results in a more efficient manner than current biotech platforms. 

Company: HotSpot Therapeutics 
Amount Raised: $65 mm
Funding Round: Series B
Date: 5/21
Lead Investor(s): S.R. One
Company Description: Hot Spot Therapeutics is an early stage biotech aiming to develop effective medicines to target “regulatory hotspots” throughout the human body. 

Company: Rallybio
Amount Raised: $145 mm
Funding Round: Series B
Date: 5/19
Lead Investor(s): Pivotal BioVenture Partners 
Company Description: Rallybio is an early stage biotech based out of New Haven, CT focused on identifying and accelerating effective treatments for patients with rare disorders. 

Company: Amplyx Pharmaceuticals 
Amount Raised:  $53 mm
Funding Round: Series C Extension
Date:  5/19
Lead Investor(s):  Soffinova Ventures 
Company Description: Amplyx is an early stage pharmaceutical company developing novel treatments to target life-threatening fungal infections

Company: Mindstrong 
Amount Raised: $100 mm
Funding Round: Series C
Date: 5/21
Lead Investor(s): ARCH Venture Partners, Foresite Capital
Company Description: Mindstrong is a mental healthcare company specizalizing in the development of a digital care platform where patients can receive effective and unlimited mental support through virtual innovation. 

Company: Amwell 
Amount Raised: $194 mm
Funding Round: Series C
Date: 5/21
Lead Investor(s): Allianz X
Company Description: Amwell is a leading digital healthcare brokerage dedicated to connecting insurers, patients, and innovators with more affordable care.